Merck & Co., Inc. (MRK)

Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to make

Will Keytruda Continue to Aid Merck's Top Line in Q3 Earnings?

How to Turn $500,000 Into a Lazy $16,500 Yearly Passive Income Stream

Merck & Co., Inc. $MRK Position Cut by Perpetual Ltd

Merck (MRK) Dips More Than Broader Market: What You Should Know

FTC says Martin Shkreli 'flagrantly and repeatedly' violated his lifetime pharma ban

Merck & Co., Inc. $MRK Position Increased by NorthCrest Asset Manangement LLC

Paul J. Diaz Elected to Merck & Co., Inc., Rahway, N.J., USA Board of Directors

Merck Showcases First-Time Pivotal Phase 3 Results From Oncology Pipeline and Continued Innovative Potential of Existing Portfolio at ESMO 2026

Jefferies cuts Merck's remigromig sales forecast after eye-disease trial raises concerns

Vaccine Stocks Rally on Reports of U.S.-led Push for Cancer Vaccines

Wall Street Bulls Look Optimistic About Merck (MRK): Should You Buy?

These 3 Stocks Are Crushing the "Magnificent Seven" This Year -- Are They Still Buys?

Merck Presents One-Year Results from the Pivotal Phase 2b/3 BRUNELLO Study Evaluating Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, in Adults with Diabetic

Merck Presents One-Year Results from the Pivotal Phase 2b/3 BRUNELLO Study Evaluating Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, in Adults with Diabetic Macular Edema at AAO 2026

Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?

Breakfast News: The Quarter in Charts

This Stock Is Up More than 560% This Year, but It Could Drop by 38%, According to Wall Street

Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies

Cantor Fitzgerald Lifts Price Targets on Four Pharma Giants Amid Mixed Growth Outlooks